Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-03-27FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for EQUATE NICOTINE (nicotine polacrilex) from Wal-Mart Stores Inc., supporting its continued market…
-
FDA approval · 2014-03-25FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
The FDA approved a supplemental application for QUITINE NICOTINE (nicotine polacrylex) from QUITINE LLC.
-
FDA approval · 2014-03-25FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex), a nicotine replacement therapy product, submit…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Nicotine Replacement Provided at a Tertiary Care Hospital [NA]
This Clinical Trial Update indicates that nicotine replacement therapy was provided at a tertiary care hospital in a completed smoking cessa…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations [NA]
A completed clinical trial evaluating tobacco treatment outreach aimed at reducing disparities in primary care populations.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources [Phase 4]
A Phase 4 study evaluating the National Cancer Institute Smoking Intervention Resources has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Incentive-based Smoking Cessation for Methadone Patients [Phase 2]
A Phase 2 clinical trial evaluating incentive-based smoking cessation among patients currently receiving methadone or buprenorphine for opio…
-
FDA approval · 2014-02-20FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
FDA approved a supplemental application for the Nicotine Transdermal System (nicotine patch) from Sam's West Inc.
-
FDA approval · 2014-02-14FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC. The approval covers an updated or e…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Examining a Text Message Intervention for Smoking Cessation [NA]
A completed clinical trial evaluated a text message-based intervention to aid smoking cessation.
-
CLINICAL_TRIALS research · 2014-01-07Clinical Trial Update: Targeted Intervention for Bipolar Smokers [NA]
This entry provides a clinical trial update for a targeted intervention aimed at smokers with bipolar disorder. The current status of the tr…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation [Phase 2, Phase 3]
The clinical trial updates report completion of Phase 2 and Phase 3 studies evaluating deep high-frequency repetitive transcranial magnetic …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Docosahexaenoic Acid (DHA) Effects on Cognitive Function, Craving and Psychosocial Factors in Heavy Cigarette Smokers [NA]
This document notes the completion of a clinical trial investigating docosahexaenoic acid (DHA) effects on cognitive function, craving, and …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Improving the Efficacy of Anti-Nicotine Immunotherapy [Phase 2]
Phase 2 results are posted for a trial evaluating anti-nicotine immunotherapy to treat nicotine dependence.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants [Phase 2, Phase 3]
A Duke University–sponsored Phase 2/Phase 3 trial evaluating tailored smoking cessation treatment for LIVE FOR LIFE participants was termina…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy [Phase 4]
Phase 4 trial update examining whether the COMT Val108/Met genetic polymorphism influences smoking cessation outcomes with nicotine replacem…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI [NA]
A completed clinical trial comparing Motivational Interviewing to Psychoeducation for smoking precontemplators with serious mental illness.
-
FDA approval · 2013-10-31FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
FDA approved a supplemental application for the Nicotine Transdermal System (nicotine patch) submitted by Sam's West Inc.
-
FDA approval · 2013-10-30FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2013-10-29FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
FDA approves a supplemental application for QUITINE NICOTINE (nicotine polacrilex) by QUITINE LLC, expanding its approved use/formulation.
-
FDA approval · 2013-10-28FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2013-10-11FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: WebQuit Online Smoking Cessation Study [Phase 1]
Phase 1 trial of the WebQuit online smoking cessation program sponsored by Fred Hutchinson Cancer Center has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Varenicline and Alcohol in Inpatient Addictions Program (IAP) [Phase 3]
A Phase 3 clinical trial evaluating varenicline for comorbid alcoholism and nicotine dependence was terminated; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Smoking Treatment and Anxiety Management Program [NA]
This clinical trial update notes the completion of a study evaluating a smoking treatment combined with an anxiety management program for ni…